Hear From Our CEO

CEO, Remco op den Kelder, shares insight into Putnam’s latest brand evolution with the alignment of 4 brands.

Read The Press Release

Putnam, an Inizio Advisory Company, is a premier strategic consulting partner for pharmaceutical and life science companies. We offer an unparalleled depth and breadth of advisory service expertise combined with scientific and technical capabilities to help our clients solve their most complex challenges and advise on the commercialization of life-changing therapies bringing preventions and treatments to those that need them.

Our Story

By The Numbers

“We are excited to have launched our united people strategy under our evolved Putnam brand and Putnam PHMR team. The latest evolution of brand strategy continues to demonstrate our commitment to bringing the best talent together across our business, to solve our clients’ biggest challenges, and differentiates Putnam as a leader in healthcare life sciences consulting market.”

Maeghan Sulham

Chief People Officer Hear from Our Leaders

“With the joining of these four teams, Putnam‘s VPA practice now provides global scale, a world class scientific and technical team to support value demonstration and HTA success, and a world class strategy team to help clients assess opportunities and challenges and navigate healthcare systems, stakeholders, and incentives to maximize patient access and value capture.”

Eric Auger

Partner, VPA Practice Lead Hear from Our Leaders

“When PHMR joined with Putnam 18 months ago, it was with one vision in mind, to become part of a best in class, truly scalable global market access company. I am delighted to say that today with the joining of Creativ-Ceutical and SmartAnalyst HEOR/RWE team under the Putnam PHMR banner, we are well on our way to realising that vision.”

Mark Ratcliffe

Found of PHMR Hear from Our Leaders

“The addition of SmartAnalyst brings a team with a unique depth of scientific and technical expertise that complements our existing early pipeline and portfolio strategy practices, deepening our ability to be a strategic partner of choice to clients ranging from emerging biotechs to large pharma, as well as leading VC and PE funds focused on the life sciences. Most importantly, our new colleagues from SmartAnalyst share Putnam’s passion for using our scientific, clinical, and commercial strategy expertise to support the development and delivery of therapeutics that advance human health.”

Matt Riordan

Partner, Commercial Practice Lead\ Hear from Our Leaders

Did You Know

Putnam has completed more than 2000 strategy projects for biopharmaceutical clients

Strategy for the Life Sciences